ABOUT 16th_ELSF
​> ATTENDEES​
​> INVESTORS​
​> PRESENTERS​
​> SPONSORS​
​> SUPPORTERS​

Sachs Associates would like to say that we have enjoyed hosting you back in-person and virtually and thank those who participated in our Sachs Spring Life Sciences Week, which incorporated the 4th Annual European HealthTech CEO Forum (EHTF) and the 16th Annual European Life Sciences CEO Forum (ELSF). A special thank you goes to the excellent line up of sponsors, chairs, panelists and presenters who made such a broad and interesting programme possible and to those who participated in-person and during the virtual week. 


The Life Sciences Week has proven to be successful in supporting our community with 456 people from 25 countries registered and over 1800 in-person & online meetings completed.   


Publicly available recordings of the sessions and presentations, which took place during the event will be added from April on SachsTV YouTube channel. 


We look forward to welcoming you again to our future events! 

Sponsors Included:

Presenters Included:

Chairs & Speakers Included:

• Adrian Dawkes, Managing Director, PharmaVentures Ltd. 
• Andrea Patricelli Malizia, CEO, IAMA Therapeutics S.r.l.
• Andreas Jurgeit, Partner, Gimv
• Andrew Sinclair, Managing Director, Abingworth LLP
• Andrin Oswald, Incoming CEO, Somagenetix AG
• Apollon Papadimitriou, CEO, IOmx Therapeutics AG
• Brian Hashemi, Executive Chairman & CEO, Novigenix SA
• Carlos Buesa, Founder & CEO, Oryzon Genomics, S.A.
• Carlos de Sousa, CEO, Ultimovacs ASA
• Chandra Leo, Investment Advisor, HBM Partners AG
• Chris Garabedian, Chairman & CEO, Xontogeny*
• Dani Bach, Partner, +ND Capital
• Dmitrij Hristodorov, Partner, Forbion
• Duncan Young, Head of BD, Redx Pharma Plc.
• Ellen Licking, Senior Director, Client Services & Communications, Real Endpoints LLC*
• Eric Halioua, President & CEO, PDC*line Pharma SA
• Esteban Pombo-Villar, CTO, TargImmune Therapeutics AG
• Fabian Buller, CBO, Neurimmune AG
• Gil Bar-Nahum, Managing Director, EMEA Head of Biotechnology, Jefferies International Ltd.
• Gita Dittmar, Executive Chair, Twelve Bio ApS
• Gregor Macdonald, VP, Head of BD & Licensing, Search & Assessment, H. Lundbeck A/S
• Göran Forsberg, CEO, Cantargia AB
• Hans Herklots, Managing Director, Second Thought
• Isabel Ferreira, Chief Business Officer, Versameb AG
• Joachim Vogt, Director Search & Evaluation International, AbbVie, Inc.
• John Stanford, Executive Director, Incubate*
• Katya Smirnyagina, Senior Partner (Life Sciences), Oxford Science Enterprises
• Kelly Curtin, Managing Director, Torreya
• Khatereh Ahmadi, Head of Search & Evaluation Business Development, Europe & Middle East, MSD
• Klaus Breiner, Managing Partner, Pureos Bioventures
• Kristen Albright, CEO, Prokarium Ltd.
• Lubor Gaal, CFO, Targovax ASA
• Lynn Durham, CEO, STALICLA SA
• Markus Hosang, General Partner & Managing Director, BioMedPartners AG
• Matthias Müllenbeck, SVP, Head Global BD & Alliance Management, Merck KGaA, Darmstadt, Germany
• Michael Altorfer, CEO, Swiss Biotech Association
• Michael Huebner, Director Early Innovation Partnering, Johnson & Johnson Innovation LLC
• Miguel Silva, Director of Strategy, OMass Therapeutics
• Miquel Vila-Perelló, CEO, SpliceBio S.L
• Modi Teicher, Chief Business Officer, FutuRx
• Nathalie ter Wengel, European Lead, Worldwide Business Development, Pfizer, Inc.
• Naveed Siddiqi, Senior Partner, Novo Holdings A/S
• Nicki Thompson, CEO, Amphista Therapeutics Ltd.
• Olav Zilian, Senior Equity Analyst - Healthcare, Pictet & Cie SA
• Paul Hermant, Partner, Bird & Bird LLP
• Paul Rennert, CEO, President & CSO, Aleta Biotherapeutics
• Peter Braun, CEO, TargImmune Therapeutics AG
• Peter Llewellyn-Davies, CEO & CFO, invIOs GmbH
• Pierre-Jean Wipff, Director Innovation & Partnerships, Biopôle SA
• Rao Movva, Novartis Distinguished Scientist & Independent Pharma & Biotech Advisor
• Regina Hodits, Managing Partner, Wellington Partners
• Renee Aguiar-Lucander, CEO, Calliditas Therapeutics AB
• Richard Ward, Executive Director, Search & Evaluation, AstraZeneca
• Ryan Richardson, Chief Strategy Officer, BioNTech SE
• Sam Fazeli, Head of Research, Senior Pharmaceuticals Analyst, Bloomberg Intelligence
• Sascha Berger, General Partner, TVM Capital Life Science
• Shuguang Yuan, CEO,  AlphaMol Science AG
• Søren Bregenholt, CEO, Alligator Bioscience AB
• Søren Møller, Managing Partner, Novo Holdings A/S
• Stephanie Léouzon, Partner & Head of Europe, Torreya
• Stephen Myatt, CEO, Macomics Ltd.
• Steve Dickman, CEO, CBT Advisors
• Tamas Schweighoffer, Co-Founding Partner, Forty51 Ventures
• Thibaut Roulon, Senior Investment Director, Bpifrance
• Thierry Laugel, Managing Partner, Kurma Partners
• Thilo Schroeder, Managing Partner, Nextech Invest Ltd.
• Thomas Hoeger, CEO, Apogenix AG
• Thomas Tan, Principal, Sound Bioventures Management AB
• Zaki Salanti, Senior Director, Head of Search & Evaluation, Novo Nordisk A/S
  

* Virtual Speaker

To learn more about presenting, exhibition or sponsorship opportunities, please fill in registration form or contact us at SachsTeam@SachsForum.com or by phone + 44 (0)203 463 4890.

Silver Sponsors:

---

Bronze Sponsors:

---

Contributing Sponsors:

---

Supporters:

---

Participating Pharmas:

---

Financial, Advisory & Investors Attending:

+ND Capital
3B Future Health Ventures
AbbVie Ventures
Abingworth LLP
AFK & Partners Asset Management LLC
AGTC Ventures LLC
AMR Action Fund GP GmbH
Anchor
Andera Partners
Apollo Health Ventures
ARTO AG
ATGN Consulting
Atlas Capital Markets
Atlas Capital Ventures LLC
AXA Investment Managers
BERNINA BioInvest Ltd.
BGV (BioGeneration Ventures)
BioMedPartners AG
BiomedVC AG
Bioqube Ventures
BIOSTART Consulting GmbH
Boehler Life Science Advice
Bootstrap Europe
Bpifrance
Breslin AG & LSFA
BROTHERS & Partners Europe
Canica Holding AG
Capricorn Partners
CD-Venture GmbH
Columbus Venture Partners
Convergence Partners AG
Corinthian Financial Management SARL
Delin Ventures
Digital Networks Plc. S.r.l.
Eliraz Ventures
Forbion
Forty51 Ventures
FutuRx
Gimv
Global Life Science Ventures GmbH
GrayBella Capital LLC
H.C. Wainwright & Co., LLC
HBM Partners AG
High-Tech Gründerfonds Management GmbH
Hitachi Ventures GmbH
HitchinRock Advisors Limited
ICF Consult Switzerland
Indaco Venture Partners SGR
Indaco Venture Partners SGR S.p.A.
Industrifonden
Inflexion Private Equity Partners
Inveready

To View All - Click Here